U.S. Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Report

U.S. Clinical Trial Equipment & Ancillary Solutions Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Value chain based analysis (Model 2)
                        1.7.3. Multivariate Analysis (Model 3)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
                        3.2.1. Market Driver Impact Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Technological Landscape
                    3.4. Pricing Model Analysis
                    3.5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
                        3.5.1. Porter’s Five Forces Analysis
                        3.5.2. PESTEL Analysis
Chapter 4. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
                    4.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    4.4. Sourcing
                        4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        4.4.2. Procurement
                            4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.2.2. Equipment
                                4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.2.3. Ancillaries
                                4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.3. Rental
                            4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.3.2. Equipment
                                4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.3.3. Ancillaries
                                4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.5. Supply/Logistics
                        4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.2. Transportation
                            4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.3. Packaging
                            4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.4. Others
                            4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.6. Service
                        4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.6.2. Calibrations
                            4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.6.3. Equipment servicing
                            4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.6.4. Others
                            4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.7. Others
                        4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
                    5.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
                    5.4. Phase I
                        5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Phase II
                        5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.6. Phase III
                        5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.7. Phase IV
                        5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Company Categorization
                        6.1.1. Market Leaders
                        6.1.2. Emerging Players
                    6.2. Company Market Share/Assessment Analysis, 2024
                    6.3. Company Profiles
                        6.3.1. Ancillare, LP
                            6.3.1.1. Company overview
                            6.3.1.2. Financial performance
                            6.3.1.3. Service benchmarking
                            6.3.1.4. Strategic initiatives
                        6.3.2. Imperial CRS, Inc.
                            6.3.2.1. Company overview
                            6.3.2.2. Financial performance
                            6.3.2.3. Service benchmarking
                            6.3.2.4. Strategic initiatives
                        6.3.3. Woodley Equipment Company Ltd.
                            6.3.3.1. Company overview
                            6.3.3.2. Financial performance
                            6.3.3.3. Service benchmarking
                            6.3.3.4. Strategic initiatives
                        6.3.4. Thermo Fisher Scientific, Inc.
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Service benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Parexel International (MA) Corporation
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Service benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Emsere (formerly MediCapital Rent)
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Service benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. Quipment SAS
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Service benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. IRM
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Service benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. Marken (UPS-United Parcel Service)
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Service benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. Myonex
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Service benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. Yourway
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Service benchmarking
                            6.3.11.4. Strategic initiatives


List of Tables

Table 1 List of abbreviations
Table 2 U.S. clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
Table 3 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
Table 4 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)


List of Figures

Fig. 1 US clinical trial equipment & ancillary solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook, 2024 (USD Million)
Fig. 17 Ancillary market outlook, 2024 (USD Million)
Fig. 18 US clinical trial equipment & ancillary solutions market dynamics
Fig. 19 Porter’s five forces analysis
Fig. 20 PESTEL analysis
Fig. 21 U.S. clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
Fig. 22 U.S. clinical trial equipment & ancillary solutions market, by type segment: Market share, 2024 & 2033
Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 US clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
Fig. 39 US clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Market participant categorization
Fig. 45 Heat map analysis

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo